Novavax confident Covid vaccine will receive FDA authorization in June after delays
Novavax is confident its Covid-19 vaccine will receive the endorsement of the Food and Drug Administration’s advisory committee early this summer, executives said this week. The FDA committee is scheduled to meet on June 7 to review Novavax’s submission. An endorsement from the committee, which is made up of independent experts, would mean the drug …
Novavax confident Covid vaccine will receive FDA authorization in June after delays Read More »
